APOE and brain neoplasm: We found that though systemic immune function was enhanced to increase circulated T cells after the treatment of ApoE-CaCP (Supplementary Figs. 19 and 20a, b), effector T cells were not significantly increased in brain tumors (Supplementary Fig. 20c, d), indicating the existence of disrupted local immune function.